MRI Tracks Cholesterol Health

Published Online: Monday, November 1, 2004

A study, reported in Circulation (October 11, 2004), showed that an advanced magnetic resonance imaging (MRI) scan can determine whether cholesterol-lowering statin drugs are succeeding in unblocking patients' clogged arteries. The researchers followed 29 patients who took simvastatin for 3 years. In an attempt to speed up the progress results of MRIs, the researchers at John Hopkins University improved their MRI's sensitivity by putting extra coil rings around the chest of each of the participants. The researchers inserted an antenna through the nose and down the esophagus of each participant.

The MRI results demonstrated artery-blocking plaque thinning after 6 months of treatment. The findings also indicated that lowdensity lipoprotein ("bad") cholesterol was the lowest in the participants in whom plaque was reduced the most. The researchers suggested that statins save lives because they take cholesterol out of the blood, not because of their secondary effects of reducing inflammation.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues